73 results
424B5
BLRX
Bioline Rx Ltd
1 Apr 24
Prospectus supplement for primary offering
10:30am
and subsequent deposit thereof with the depositary and delivery of ADSs.
S - 11
PLAN OF DISTRIBUTION
Pursuant to an engagement agreement, we have engaged … and warrants pursuant to this prospectus supplement and accompanying prospectus. Under the terms of the engagement agreement, the placement agent has agreed
20-F/A
2023 FY
BLRX
Bioline Rx Ltd
26 Mar 24
Annual report (foreign) (amended)
4:57pm
engagement regarding such matters. In addition, new sustainability rules and regulations have been adopted and may continue to be introduced in various … and recommending the engagement, compensation or termination of engagement of our independent registered public accounting firm to our board of directors
6-K
EX-99
BLRX
Bioline Rx Ltd
30 Aug 23
Current report (foreign)
6:45am
, and with the understanding that on the basis of such authorization and engagement by HS Tech, Gloria Biosciences will conduct all of the activities under the License … under this Agreement to any other third party or any replacement or adjustment of HS Tech’s engagement or authorization of Gloria Biosciences
6-K
EX-10.3
neuvmunm 5ybv
21 Sep 22
Current report (foreign)
8:00am
424B5
gbqlu62tx7os5u0inn
20 Sep 22
Prospectus supplement for primary offering
4:30pm
6-K
EX-99
mx8eo2c1 ti3s2b
27 May 22
2022 Annual General Meeting of Shareholders
4:30pm
6-K
EX-10.1
cp7h2tpe
3 Sep 21
Current report (foreign)
4:30pm
6-K
EX-99
m3be7
21 Jan 21
Amended and Restated Underwriting Agreement
4:32pm
6-K
EX-99
6w3oh k4u
21 Jan 21
Amended and Restated Underwriting Agreement
4:32pm
424B5
ryiq 4t903cnya2
21 Jan 21
Prospectus supplement for primary offering
4:31pm
424B5
wiywflvwdhcy rk7xmm
19 Jan 21
Prospectus supplement for primary offering
5:00pm
6-K
EX-10.1
tia25rxzs4zsbcly
25 Sep 20
Current report (foreign)
4:33pm
424B5
jtkmj01m16o42
3 Jun 20
Prospectus supplement for primary offering
8:33am
6-K
EX-99
d8vod6wiopicf3 rvb
3 Jun 20
Current report (foreign)
8:30am
424B5
4nyjfq m0lvg4qs
28 May 20
Prospectus supplement for primary offering
12:00pm
6-K
EX-10.3
a0bsx80 k3
28 May 20
Current report (foreign)
11:56am